pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-190b |
Genomic Coordinates | chr1: 154193665 - 154193743 |
Description | Homo sapiens miR-190b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-190b |
Sequence | 11| UGAUAUGUUUGAUAUUGGGUU |31 |
Evidence | Not_experimental |
Experiments | |
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BCL2L13 | ||||||||||||||||||||
Synonyms | BCL-RAMBO, Bcl2-L-13, MIL1 | ||||||||||||||||||||
Description | BCL2 like 13 | ||||||||||||||||||||
Transcript | NM_015367 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on BCL2L13 | |||||||||||||||||||||
3'UTR of BCL2L13 (miRNA target sites are highlighted) |
>BCL2L13|NM_015367|3'UTR 1 GAGGCTTTTCAGAAGAGAAAGACAGAAGGATGTAAGGTTGGAGTTGTATTGGCTGGAATTTGAACCTCCAGCAGCTGTCT 81 GGACATTTGTGGAACACTCTGGGATAATTGGGGACTTCTGCTCAACATGGCAGTGGCATGTTAGGCATGTTAGGGCTTGA 161 GGTGGGGCATTCACATTCATCTGACTGTAAATCCCAAGGGCCTCCGCTCATGCTAAATTGAGAATCTTAGGGGTAAAGCA 241 CCCCCTCCAGGACCGGGTTTCTCAGCCTTGGCACTAGTGCTGTTCTGACCATTCTCTGTGTTGGGGCTGTCCTGTGTGTG 321 GTGGGCTCCACCCACTAGATGCCAGTGGCACCCCCTCCCAGAGATGACAAACGAAAATGTCTCTAGACATTGCCAAATGT 401 CCCGTGTGAACATCCCCTATTGAGACCCACTGCTTTAGCGAGAGAGGGTTTACTTAGGAAGAATTGGGATAGAAATTCCC 481 AGCTGAGAGAACTTAGCTGTGGGCTCCTCAGCTACTGACTTCTTAGCTCTTAATCCCCTTAGAATTTCATCTTTCTCGAT 561 GAGCAGGCTCTGCACCCACTCTTTTTTTGCCCCCCGCCCTCATCCTGGAGTGTGAGGGTGCTCGCCCGTACTCTCAGCTG 641 CCTCTCAGGGACTGCACTGTTCCTCTTCACCCCCAGGTTCCTGCTAAGATCCCACGGGCGAGGGCTTGCTCTGGACTCAG 721 TCTGTCAAGTCCCCGAAGCTTCCTGCAGCTCCACCTTGTAAAAATGCTGCCTTTGGGAATCTTCGAAATATGTACACAGA 801 GAAAATCACATGAAGGAGACCTGGGGTCCCCACTTGTGAGTGCAACTGCAAGTAACTCTGGCTAGAGAGACACATGTGTC 881 TTGTGTCAAGGCAGGAGGATAACCTGGATGACCTTCTGAGGTCTCTTCAGCCCTTTTCGCTAGTGGTCACCCACCACCAT 961 GGTTACTTGCCAGCAACATCTCTATTGCTGGATGGTCCCTGTCTATAACCTTGGGCTAGTATATTTTTTCCAATATGGGA 1041 CCTTAGTCTTACTACTGATGAGTTCTATGGGTCTCTTGCTAGGGGGTAAGGATTTTTATTCTTGGGCTTATAGAGCCAGT 1121 TAGATCATAATTCTTATGAAATAGAGAGTGTCCTAAATATCACTGAAATAAAAAGTAGGAAAAAGAAGCTTGAATTTTAA 1201 GACTGAGGCTGCTCTGCAGATTCTAGTTTGGCTTTCAGAGTTCAAGAGTGGTGGCATCTTCACCTGAATTCTTCAATGCC 1281 AGGGTAATAAACCAAAATAGTCCTAATCAGTATATGCTAGTTGAGCATCGGCATAATTTTCTTTCCTCTGGCTGATCCCA 1361 GCCCTAAAGGAAGGGTAGACCCGTGTCTTTCCAGCCCTAAAGGAAGGGTAGACCCGTGTCTTTCCAGCCCTAAAGGAAGG 1441 GCAGACCCGTGTCTTTCCATGCCCGAGGGCCACGACGTCACTATGCAGGGCACACGTGGCTTGGTTTAAAAAGGTCATCT 1521 TAGATTTATCTTAGTAAATGTAATAAATTATTTTTTAGATCTTGAAATTTATAATAAAAATACTTTACCTACCCTGATCA 1601 CCAAAACCTGATGTTTTAAATGTGCTTTCTTTTTGAAATTTATGTTTTCAAATAAAATCTCCCTAAAGCAATATTTAAAA 1681 ATTGGTCAAAACAAGGTCTGGGAGTATGTTTGTGTGTCTTTCCAGCTTTATCCTGTAGCGTGTCTTTGTTCTGTGTTTTA 1761 GTGTCCCATTTAGGGAGTGATGTTTTAAGGGTTTTTGTGTACTTGGATTAAGTAATTAGAGGTGAGTGGGGGGAATGGGA 1841 TTATTGAGGCAATGATTTTTTTCTTCATGGGCTCTGATAGTTGCATTGATTGTTCTGTATTCTAATTGCTATATTTGTGT 1921 TTGCATAGGTGAAGAGCAAACTGGTGCGTTATCTTGATTTTTAAAAAGTAATAAATCCTATGAGTTCCAGTATTAACACT 2001 TGCCAGTTCTGGATCCTCACACCCATTGGCTGAGCGCATTCAAGCACCAATCGAAGCCAGGTTCATCTCTGAGCTGCTGA 2081 AAGGAGGTGTGAGGCTTAGGAAATTGGAGCCTGTGTTGCCCACGAAAGGAAAGAATAAGGAAGAAATGTGGTATGGAAGC 2161 GGCTACTTGCTGCTTTATTTTCCCACCTGTTAGACATTCCTCCACAGTGATTTGGCCAGTTGTATTTCACGGTAATGGAA 2241 CTAGATAGTGTTTTCCATTGGCTTTCTCTGGTAGCTCTTGGTCAGCTCCTGAGTTAACAGGATGTGGCAGCATCCCTGTT 2321 CTTCCTTCACGTCCTCACCCTCTGCCTCCAGCAGTGGAAGGGAACAGCCCTCATGAGGACTGCTTCCTACTGCAGCTCCT 2401 GCTTTTTGCTCATACATTTAAAAAACTATTTCTCAAGCTTCCCCTCCTTTTGGGGGGAGGAGCTGATAGTAGGAGGCCAT 2481 TCCTTCCACCTCCAACTTATACCCTCTAAGTCTAAGGTGAAGGAAAGATTCAGAATAAATCCAACTTGTTTATAGAAAAG 2561 TTCTTGTTAGTCCTTAGACCTCATCTCAACTGCTCTGTTGAAGGTAATGATTTATTGGGGGGAAAAAACAACGCCAATTT 2641 ATCCTCTCTGTATTAAAGTGATAATTCTGGGCCCACAGAAATCAGTCAGTACCTGCGGTGTGCCTTAAGGGGACTCTCAT 2721 GATCATCATTCCCTTCTAGAGAACATTCTAGATGAAGAAATGCAACTGTTGACCTTCTGGTTCACCCATCTCCCCCTCGA 2801 GGCATTCTTGATACCCCTTCTCACCTGCATTTCTGTCCCAGGGATACCAGATGCAGCCACTACCTAACTAGGCTTGTCCT 2881 GGGGGAGTGAGCCGTGAACCTGGAGACATGGCTTTGACCCACAGCTACTGTTCATTTCCTCAGGCTTTGCGCTGATTCCC 2961 TCAATAATATGACAGTAAGGCAAGTAGTCTCCTTGCCTTTCTCCTGAAAGGTATGAGATGTGGACATTTCAGTGTTTGAA 3041 TTATTTTAAGAGATGTTTTATAGAAATAAAACGTTTTGTAGCTAAGAATTTTCCCTTTCTCTTAATTTCTTACATCTTTC 3121 CACACAAACTTATCTTTCCAAGAATTTGAGGTGGTGATCATACCCATCAAGACGGCCTTGTAGGCTATCTGATTGCTAAC 3201 AGACACGACCTAGAGCTTCTGCCCAAATTCCCACACAAGCATTATCTCGTTTAACATCTCAGCGACATACTGGATACCAG 3281 AATAATGTTTCCTCTTCTCTGGTGCACCAAAACCTGCCCTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 23786.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000355028.3 | 3UTR | cuuccacauaucacugccaccucc |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000355028.3 | 3UTR | cuuccacauaucacugccaccucccug |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
60 hsa-miR-190b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT054581 | IGF1 | insulin like growth factor 1 | 4 | 1 | ||||||||
MIRT066966 | ATXN7L3B | ataxin 7 like 3B | 2 | 2 | ||||||||
MIRT192449 | SPRED1 | sprouty related EVH1 domain containing 1 | 2 | 2 | ||||||||
MIRT250414 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT306294 | KLHL24 | kelch like family member 24 | 2 | 2 | ||||||||
MIRT355845 | SGMS2 | sphingomyelin synthase 2 | 2 | 4 | ||||||||
MIRT437770 | MTMR6 | myotubularin related protein 6 | 1 | 1 | ||||||||
MIRT437771 | MTMR6 | myotubularin related protein 6 | 1 | 1 | ||||||||
MIRT437772 | Mtmr6 | myotubularin related protein 6 | 1 | 1 | ||||||||
MIRT444672 | CDKL2 | cyclin dependent kinase like 2 | 2 | 2 | ||||||||
MIRT446389 | PCDHB11 | protocadherin beta 11 | 2 | 2 | ||||||||
MIRT446634 | SDC3 | syndecan 3 | 2 | 2 | ||||||||
MIRT449410 | TRIM5 | tripartite motif containing 5 | 2 | 2 | ||||||||
MIRT449560 | GPC5 | glypican 5 | 2 | 2 | ||||||||
MIRT469928 | PTPRJ | protein tyrosine phosphatase, receptor type J | 2 | 6 | ||||||||
MIRT473736 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT474210 | LDHA | lactate dehydrogenase A | 2 | 2 | ||||||||
MIRT474583 | KLF6 | Kruppel like factor 6 | 2 | 2 | ||||||||
MIRT476732 | FOXN2 | forkhead box N2 | 2 | 2 | ||||||||
MIRT478455 | DAB2 | DAB2, clathrin adaptor protein | 2 | 2 | ||||||||
MIRT495327 | ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif 8 | 2 | 4 | ||||||||
MIRT498615 | MTRNR2L10 | MT-RNR2-like 10 | 2 | 12 | ||||||||
MIRT501734 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT501849 | MTRNR2L8 | MT-RNR2-like 8 | 2 | 14 | ||||||||
MIRT504678 | CYGB | cytoglobin | 2 | 4 | ||||||||
MIRT506517 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 6 | ||||||||
MIRT507984 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT508444 | ZNF608 | zinc finger protein 608 | 2 | 4 | ||||||||
MIRT511366 | IL6ST | interleukin 6 signal transducer | 2 | 4 | ||||||||
MIRT520515 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT524571 | CALML4 | calmodulin like 4 | 2 | 4 | ||||||||
MIRT531896 | INVS | inversin | 2 | 4 | ||||||||
MIRT533916 | TATDN2 | TatD DNase domain containing 2 | 2 | 2 | ||||||||
MIRT537503 | FAM13B | family with sequence similarity 13 member B | 2 | 2 | ||||||||
MIRT541689 | CCDC160 | coiled-coil domain containing 160 | 2 | 8 | ||||||||
MIRT544419 | ZNF460 | zinc finger protein 460 | 2 | 4 | ||||||||
MIRT544615 | CSDE1 | cold shock domain containing E1 | 2 | 2 | ||||||||
MIRT545076 | IL7R | interleukin 7 receptor | 2 | 2 | ||||||||
MIRT545849 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT547436 | MED4 | mediator complex subunit 4 | 2 | 2 | ||||||||
MIRT550157 | ZNF223 | zinc finger protein 223 | 2 | 4 | ||||||||
MIRT553948 | STAMBP | STAM binding protein | 2 | 2 | ||||||||
MIRT554395 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT555667 | PGAM4 | phosphoglycerate mutase family member 4 | 2 | 4 | ||||||||
MIRT564193 | PM20D2 | peptidase M20 domain containing 2 | 2 | 2 | ||||||||
MIRT566792 | MKL2 | MKL1/myocardin like 2 | 2 | 2 | ||||||||
MIRT566843 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT572516 | KIAA0232 | KIAA0232 | 2 | 2 | ||||||||
MIRT607428 | NOTCH2NL | notch 2 N-terminal like | 2 | 10 | ||||||||
MIRT627779 | RAB30 | RAB30, member RAS oncogene family | 2 | 2 | ||||||||
MIRT635159 | ENO4 | enolase family member 4 | 2 | 2 | ||||||||
MIRT642159 | ADCYAP1R1 | ADCYAP receptor type I | 3 | 2 | ||||||||
MIRT646205 | DUSP10 | dual specificity phosphatase 10 | 2 | 2 | ||||||||
MIRT657007 | KCNMB4 | potassium calcium-activated channel subfamily M regulatory beta subunit 4 | 2 | 2 | ||||||||
MIRT665817 | TMEM161B | transmembrane protein 161B | 2 | 2 | ||||||||
MIRT667488 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 2 | 2 | ||||||||
MIRT707098 | ZNF850 | zinc finger protein 850 | 2 | 2 | ||||||||
MIRT708719 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT735521 | HUS1 | HUS1 checkpoint clamp component | 3 | 0 | ||||||||
MIRT736644 | AGPAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|